PubRank

C Cordonnier

Author PubWeight™ 138.18‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3--2009 update. Bone Marrow Transplant 2010 3.46
2 Detection of Aspergillus species DNA in bronchoalveolar lavage samples by competitive PCR. J Clin Microbiol 1995 2.28
3 An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantation. Bone Marrow Transplant 2003 2.19
4 Comparison of 7.0-T T₂*-magnetic resonance imaging of cerebral bleeds in post-mortem brain sections of Alzheimer patients with their neuropathological correlates. Cerebrovasc Dis 2011 2.05
5 Spinal cord infarction: clinical and magnetic resonance imaging findings and short term outcome. J Neurol Neurosurg Psychiatry 2004 1.95
6 Cidofovir for cytomegalovirus infection and disease in allogeneic stem cell transplant recipients. The Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Blood 2001 1.93
7 An EORTC multicentre prospective survey of invasive aspergillosis in haematological patients: diagnosis and therapeutic outcome. EORTC Invasive Fungal Infections Cooperative Group. J Infect 1998 1.82
8 Cause of death after allogeneic haematopoietic stem cell transplantation (HSCT) in early leukaemias: an EBMT analysis of lethal infectious complications and changes over calendar time. Bone Marrow Transplant 2005 1.79
9 Management of HSV, VZV and EBV infections in patients with hematological malignancies and after SCT: guidelines from the Second European Conference on Infections in Leukemia. Bone Marrow Transplant 2008 1.78
10 Respiratory virus infections after stem cell transplantation: a prospective study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 2001 1.74
11 Real-time PCR for diagnosis and follow-up of Toxoplasma reactivation after allogeneic stem cell transplantation using fluorescence resonance energy transfer hybridization probes. J Clin Microbiol 2000 1.73
12 Early seizures in intracerebral hemorrhage: incidence, associated factors, and outcome. Neurology 2011 1.65
13 Localization of E. coli endonuclease I. Biochem Biophys Res Commun 1965 1.64
14 Serum Aspergillus galactomannan antigen testing by sandwich ELISA: practical use in neutropenic patients. J Infect 1997 1.59
15 Management of CMV, HHV-6, HHV-7 and Kaposi-sarcoma herpesvirus (HHV-8) infections in patients with hematological malignancies and after SCT. Bone Marrow Transplant 2008 1.56
16 Comparison of serum galactomannan antigen detection and competitive polymerase chain reaction for diagnosing invasive aspergillosis. Clin Infect Dis 1998 1.51
17 Timed sequential chemotherapy for previously treated patients with acute myeloid leukemia: long-term follow-up of the etoposide, mitoxantrone, and cytarabine-86 trial. J Clin Oncol 1995 1.48
18 Vaccination of hematopoietic cell transplant recipients. Bone Marrow Transplant 2009 1.42
19 Antifungal prophylaxis in haematology patients: the role of voriconazole. Clin Microbiol Infect 2012 1.40
20 Evolution of bacterial susceptibility to antibiotics during a six-year period in a haematology unit. J Hosp Infect 1995 1.39
21 Absence of graft-versus-leukemia (GVL) effect by leucocytes transfused: a prospective randomized trial in acute myeloid leukemia (AML) patients. Br J Haematol 1991 1.37
22 Toxoplasmosis after hematopoietic stem cell transplantation. Clin Infect Dis 2000 1.34
23 The role of mediastinoscopy in the diagnosis of mediastinal lymphadenopathy. Eur J Cardiothorac Surg 1998 1.32
24 "Fast" and "slow" muscle fibres in hindlimb muscles of adult rats regenerate from intrinsically different satellite cells. J Physiol 2004 1.27
25 European guidelines for diagnosis and treatment of adenovirus infection in leukemia and stem cell transplantation: summary of ECIL-4 (2011). Transpl Infect Dis 2012 1.26
26 Vaccination of stem cell transplant recipients: recommendations of the Infectious Diseases Working Party of the EBMT. Bone Marrow Transplant 2005 1.25
27 Cidofovir for adenovirus infections after allogeneic hematopoietic stem cell transplantation: a survey by the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 2003 1.24
28 Alveolar hemorrhage. Diagnostic criteria and results in 194 immunocompromised hosts. Am J Respir Crit Care Med 1995 1.20
29 Small bowel incarceration in a broad ligament defect. Surg Endosc 2002 1.16
30 Impact of previous aspergillosis on the outcome of bone marrow transplantation. Clin Infect Dis 1998 1.15
31 Acute promyelocytic leukemia in 57 previously untreated patients. Cancer 1985 1.14
32 A retrospective series of gut aspergillosis in haematology patients. Clin Microbiol Infect 2011 1.13
33 Usefulness of genotyping with microsatellite markers to investigate hospital-acquired invasive aspergillosis. J Hosp Infect 1999 1.12
34 Reverse seroconversion of hepatitis B after allogeneic bone marrow transplantation: a retrospective study of 37 patients with pretransplant anti-HBs and anti-HBc. Transplantation 1998 1.11
35 Pulmonary complications occurring after allogeneic bone marrow transplantation. A study of 130 consecutive transplanted patients. Cancer 1986 1.05
36 The impact of cerebral amyloid angiopathy on the occurrence of cerebrovascular lesions in demented patients with Alzheimer features: a neuropathological study. Eur J Neurol 2011 1.03
37 Prospective study of toxoplasma reactivation by polymerase chain reaction in allogeneic stem-cell transplant recipients. Transpl Infect Dis 2000 1.03
38 Bacteremia due to Capnocytophaga species in patients with neutropenia: high frequency of beta-lactamase-producing strains. Clin Infect Dis 1999 1.02
39 Secondary alveolar proteinosis in cancer patients. Support Care Cancer 1996 1.01
40 [Collapsing glomerulopathy and cytomegalovirus, what are the links?]. Presse Med 2000 1.00
41 Sclerodermatous chronic graft-versus-host disease. Analysis of seven cases. J Am Acad Dermatol 1992 0.99
42 Outbreaks of infectious diseases in stem cell transplant units: a silent cause of death for patients and transplant programmes. Bone Marrow Transplant 2004 0.98
43 Quality control for the diagnosis of Toxoplasma gondii reactivation in SCT patients using PCR assays. Bone Marrow Transplant 2001 0.98
44 Long lasting IgG subclass and antibacterial polysaccharide antibody deficiency after allogeneic bone marrow transplantation. Blood 1987 0.98
45 Toxoplasmosis after hematopoietic stem transplantation. Report of a 5-year survey from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 2000 0.98
46 Genetic associations with brain microbleeds: Systematic review and meta-analyses. Neurology 2011 0.97
47 Treatment of interstitial pneumonitis due to cytomegalovirus with ganciclovir and intravenous immune globulin: experience of European Bone Marrow Transplant Group. Clin Infect Dis 1992 0.97
48 [Hemoptysis and spontaneous rupture of a primary renal angiosarcoma: a case report]. J Radiol 2010 0.96
49 Diagnostic yield of bronchoalveolar lavage in pneumonitis occurring after allogeneic bone marrow transplantation. Am Rev Respir Dis 1985 0.96
50 Late toxoplasmosis evidenced by PCR in a marrow transplant recipient. Bone Marrow Transplant 1995 0.95
51 Early myosin switching induced by nerve activity in regenerating slow skeletal muscle. Cell Struct Funct 1997 0.95
52 Placebo response in cluster headache trials: a review. Cephalalgia 2003 0.95
53 Long-term impact of subclinical inflammation diagnosed by protocol biopsy one year after renal transplantation. Am J Transplant 2011 0.94
54 European guidelines for prevention and management of influenza in hematopoietic stem cell transplantation and leukemia patients: summary of ECIL-4 (2011), on behalf of ECIL, a joint venture of EBMT, EORTC, ICHS, and ELN. Transpl Infect Dis 2013 0.93
55 European survey of herpesvirus resistance to antiviral drugs in bone marrow transplant recipients. Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant 1996 0.93
56 A comparative study of acid deoxyribonucleases extracted from different tissues and species. Can J Biochem 1968 0.91
57 Treatment of relapsing acute promyelocytic leukemia by all-trans retinoic acid therapy followed by timed sequential chemotherapy and stem cell transplantation. APL Study Group. Acute promyelocytic leukemia. Leukemia 2000 0.91
58 Influence of clinical status on the efficiency of stored platelet transfusion. Br J Haematol 1994 0.89
59 Posttransplantation lymphoproliferative disorder mimicking a nonspecific lymphocytic pleural effusion in a bone marrow transplant recipient. A case report. Acta Cytol 1999 0.88
60 Practices for cytomegalovirus diagnosis, prophylaxis and treatment in allogeneic bone marrow transplant recipients: a report from the Working Party for Infectious Diseases of the EBMT. Bone Marrow Transplant 1993 0.88
61 Aspergillus fumigatus causes in vitro electrophysiological and morphological modifications in human nasal epithelial cells. Histol Histopathol 2002 0.87
62 Immunogenicity of Haemophilus influenzae type b conjugate vaccine in allogeneic bone marrow recipients. J Infect Dis 1992 0.87
63 EFNS-ENS/EAN Guideline on concomitant use of cholinesterase inhibitors and memantine in moderate to severe Alzheimer's disease. Eur J Neurol 2015 0.87
64 Regionally limited or rare infections: prevention after hematopoietic cell transplantation. Bone Marrow Transplant 2009 0.87
65 Septic hip arthritis after multiple injections into the joint of hyaluronate and glucocorticoid. Rev Rhum Engl Ed 1999 0.86
66 Use of intravenous immune globulin in addition to antiviral therapy in the treatment of CMV gastrointestinal disease in allogeneic bone marrow transplant patients: a report from the European Group for Blood and Marrow Transplantation (EBMT). Infectious Diseases Working Party of the EBMT. Bone Marrow Transplant 1998 0.86
67 Effect of priming with granulocyte-macrophage colony-stimulating factor in younger adults with newly diagnosed acute myeloid leukemia: a trial by the Acute Leukemia French Association (ALFA) Group. Leukemia 2007 0.86
68 Iron deposits in post-mortem brains of patients with neurodegenerative and cerebrovascular diseases: a semi-quantitative 7.0 T magnetic resonance imaging study. Eur J Neurol 2014 0.85
69 Toxic epidermal necrolysis after bone marrow transplantation: study of nine cases. J Am Acad Dermatol 1990 0.85
70 [Infections of the central nervous system in malignant hemopathies]. Rev Neurol (Paris) 1986 0.85
71 Lenograstim after autologous peripheral blood progenitor cell transplantation: results of a double-blind, randomized trial. Bone Marrow Transplant 2004 0.85
72 Aspergillosis prior to bone marrow transplantation. Infectious Diseases Working Party of the EBMT and the EORTC Invasive Fungal Infections Cooperative Group. Bone Marrow Transplant 1995 0.85
73 Granulocyte-macrophage colony-stimulating factor (GM-CSF) to increase efficacy of intensive sequential chemotherapy with etoposide, mitoxantrone and cytarabine (EMA) in previously treated acute myeloid leukemia: a multicenter randomized placebo-controlled trial (EMA91 Trial). Leukemia 1999 0.85
74 Detection of microbleeds in post-mortem brains of patients with frontotemporal lobar degeneration: a 7.0-Tesla magnetic resonance imaging study with neuropathological correlates. Eur J Neurol 2012 0.85
75 Relationship between clinical and BK virological response in patients with late hemorrhagic cystitis treated with cidofovir: a retrospective study from the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 2012 0.84
76 Impact of liver disease and hepatitis infections on allogeneic bone marrow transplantation in Europe: a survey from the European Bone Marrow Transplantation (EBMT) Group--Infectious Diseases Working Party. Bone Marrow Transplant 1994 0.84
77 Quinine improves the results of intensive chemotherapy in myelodysplastic syndromes expressing P glycoprotein: results of a randomized study. Br J Haematol 1998 0.84
78 Human recombinant growth hormone increases small bowel lengthening after massive small bowel resection in piglets. J Pediatr Surg 1997 0.84
79 Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe. Bone Marrow Transplant 2002 0.84
80 Mucormycosis after allogeneic haematopoietic stem cell transplantation: a French Multicentre Cohort Study (2003-2008). Clin Microbiol Infect 2012 0.84
81 Effects of calcium-free solution, calcium antagonists, and the calcium agonist BAY K 8644 on mechanical responses of skeletal muscle from patients susceptible to malignant hyperthermia. Anesthesiology 1991 0.83
82 Mixed blood chimerism in T cell-depleted bone marrow transplant recipients: evaluation using DNA polymorphisms. Blood 1987 0.83
83 [Chronic interstitial nephritis induced by 5-aminosalicylic acid: a new case report]. Nephrologie 2002 0.83
84 Splenic rupture due to aspergillosis. Nouv Rev Fr Hematol 1983 0.83
85 Superficial siderosis of the central nervous system: a post-mortem 7.0-tesla magnetic resonance imaging study with neuropathological correlates. Cerebrovasc Dis 2013 0.82
86 [Choriocapillaris occlusion in Moschowitz's disease (author's transl)]. J Fr Ophtalmol 1981 0.82
87 Allogeneic bone marrow transplantation for adult acute lymphoblastic leukemia in first complete remission: factors predictive of transplant-related mortality and influence of total body irradiation modalities. Bone Marrow Transplant 1993 0.82
88 Hepatitis C virus infection and allogeneic bone marrow transplantation. Transplantation 1994 0.82
89 A possible predictive test for graft-versus-host disease in bone marrow graft recipients: the mixed-epidermal cell-lymphocyte reaction. Transplantation 1986 0.82
90 Pulmonary veno-occlusive disease after bone marrow transplantation. Thorax 1984 0.82
91 Age-adapted induction treatment of acute lymphoblastic leukemia in the elderly and assessment of maintenance with interferon combined with chemotherapy. A multicentric prospective study in forty patients. French Group for Treatment of Adult Acute Lymphoblastic Leukemia. Leukemia 1997 0.82
92 Cerebrovascular lesions in patients with frontotemporal lobar degeneration: a neuropathological study. Neurodegener Dis 2012 0.81
93 Evaluation of three assays on alveolar lavage fluid in the diagnosis of cytomegalovirus pneumonitis after bone marrow transplantation. J Infect Dis 1987 0.81
94 Environmental prevention of infection in stem cell transplant recipients: a survey of the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Transpl Infect Dis 2013 0.81
95 Risk assessment in adult acute lymphoblastic leukaemia before early haemopoietic stem cell transplantation with a geno-identical donor: an easy clinical prognostic score to identify patients who benefit most from allogeneic haemopoietic stem cell transplantation. Leukemia 2003 0.81
96 Predictive value of host-specific donor helper T-cell precursor frequency for acute graft-versus-host disease and relapse in HLA-identical siblings receiving allogeneic bone marrow transplantation for hematological malignancies. Transplantation 1997 0.81
97 Frequent detection of minimal residual disease by use of the polymerase chain reaction in long-term survivors after bone marrow transplantation for chronic myeloid leukemia. Leukemia 1990 0.80
98 [Placental chorioangiomas diagnosed during the second trimester of pregnancy: four cases]. J Gynecol Obstet Biol Reprod (Paris) 2002 0.80
99 Bronchoalveolar lavage in immunocompromised patients. Clinical and functional consequences. Chest 1992 0.80
100 Autologous reconstitution combined with durable leukemic remission after allogeneic BMT for CML: absence of persistence of a donor-derived T cell effector population. Bone Marrow Transplant 2001 0.80
101 [Mycologic surveillance of the environment for preventive invasive aspergillosis. Proposals for standardization of the methodologies and implementation]. Presse Med 2002 0.80
102 Fatal primary cutaneous aspergillosis in a bone marrow transplant recipient: nosocomial acquisition in a laminar-air flow room. J Hosp Infect 1997 0.80
103 High levels of anti-cytoskeleton autoantibodies are frequently associated with chronic GVHD. Br J Haematol 1987 0.79
104 Sarcoidosis and the kidney: not only the granulomatous interstitial nephritis. Clin Nephrol 2009 0.79
105 [Bladder tumor targeting by Hexvix(®) fluorescence: 4 years results after prospective monocentric evaluation]. Prog Urol 2013 0.79
106 Intensive sequential chemotherapy with mitoxantrone and continuous infusion etoposide and cytarabine for previously treated acute myelogenous leukemia. Blood 1991 0.78
107 Pulmonary fibrosis subsequent to high doses of CCNU for chronic myeloid leukemia. Cancer 1983 0.78
108 [High PSA and total prostatectomy: specific and overall 10-year survival]. Prog Urol 2008 0.78
109 Failure of a CD18/anti-LFA1 monoclonal antibody infusion to prevent graft rejection in leukemic patients receiving T-depleted allogeneic bone marrow transplantation. Transplantation 1989 0.78
110 Facilities available in French hospitals treating acute stroke patients: comparison with 24 other European countries. J Neurol 2009 0.78
111 Immunisations after bone marrow transplantation: results of a European survey and recommendations from the infectious diseases working party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 1995 0.78
112 Quinine improves results of intensive chemotherapy (IC) in myelodysplastic syndromes (MDS) expressing P-glycoprotein (PGP). Updated results of a randomized study. Groupe Français des Myélodysplasies (GFM) and Groupe GOELAMS. Adv Exp Med Biol 1999 0.78
113 Central nervous system relapses after bone marrow transplantation for acute lymphoblastic leukemia in remission. Cancer 1989 0.78
114 Influence of chronic stretching upon rat soleus muscle during non-weight-bearing conditions. Pflugers Arch 1994 0.78
115 Interstitial pneumonitis and venocclusive disease of the liver after bone marrow transplantation. Radiother Oncol 1990 0.78
116 Calcineurin activity as a functional index of immunosuppression after allogeneic stem-cell transplantation. Transplantation 2004 0.78
117 High resolution HLA class I and II typing and CTLp frequency in unrelated donor transplantation: a single-institution retrospective study of 69 BMTs. Bone Marrow Transplant 2001 0.78
118 Venocclusive disease of the liver after allogeneic bone marrow transplantation in man. Int J Radiat Oncol Biol Phys 1988 0.78
119 Galactomannan and polymerase chain reaction for the diagnosis of primary digestive aspergillosis in a patient with acute myeloid leukaemia. J Infect 2001 0.78
120 Allogeneic stem cell transplantation in second rather than first complete remission in selected patients with good-risk acute myeloid leukemia. Bone Marrow Transplant 2005 0.78
121 The epidemiology of invasive Streptococcus pneumoniae infections in onco-haematology and haematopoietic stem cell transplant patients in France. Are the serotypes covered by the available anti-pneumococcal vaccines? Clin Microbiol Infect 2009 0.78
122 Isepamicin once daily plus ceftriaxone versus amikacin plus ceftriaxone in febrile neutropenic patients. J Chemother 1995 0.77
123 Allogeneic bone marrow transplantation in adults with acute lymphoblastic leukemia in first complete remission. J Clin Oncol 1988 0.77
124 Oxalic acid level in bronchoalveolar lavage fluid from patients with invasive pulmonary aspergillosis. Am Rev Respir Dis 1985 0.77
125 [Spinal melanocytic schwannoma with malignant course. Microscopic and ultrastructural study of a case]. Arch Anat Cytol Pathol 1995 0.77
126 Large granular lymphocytes in bronchoalveolar lavage fluids from immunocompromised patients with cytomegalovirus pneumonitis. Am J Clin Pathol 1986 0.77
127 The effects of mesenteric ischemia on ileal colonization, intestinal integrity, and bacterial translocation in newborn piglets. Pediatr Surg Int 2001 0.77
128 Cytomegalovirus encephalitis occurring after bone marrow transplantation. Scand J Haematol 1983 0.77
129 Effect of BN 50727 on pathological findings and tissue platelet activating factor levels during ileal ischemia in newborn piglets. J Pediatr Surg 1996 0.77
130 [Mesothelial cyst of the adrenal gland]. Ann Pathol 2000 0.76
131 [Cholestatic icterus and agranulocytosis due to ticlopidine]. Gastroenterol Clin Biol 1982 0.76
132 Timed sequential chemotherapy for advanced acute myeloid leukemia. Hematol Cell Ther 1996 0.76
133 In vitro inhibition of hematopoiesis by HNK1, DR-positive T cells and monocytes after allogeneic bone marrow transplantation. Exp Hematol 1987 0.76
134 Stroke research priorities for the next decade--a supplement statement on intracranial haemorrhage. Cerebrovasc Dis 2007 0.76
135 Stroke-related seizures in patients with a partial anterior circulation syndrome. Acta Neurol Belg 2008 0.76
136 [BCG osteoarthritis on knee prosthesis after intra-vesical BCG therapy]. Rev Rhum Mal Osteoartic 1992 0.75
137 Severity of illness scores: are they useful in febrile neutropenic adult patients in hematology wards? A prospective multicenter study. Crit Care Med 2001 0.75
138 Acquired autoimmune thrombocytopenia after allogeneic bone marrow transplantation. Br J Haematol 1985 0.75
139 Better scoring for better care? J Neurol Neurosurg Psychiatry 2006 0.75
140 [Bone marrow necrosis disclosing multiple myeloma of bone]. Presse Med 1985 0.75
141 Impact of nonmyeloablative conditioning regimens on the occurrence of pure red cell aplasia after ABO-incompatible allogeneic haematopoietic stem cell transplantation. Vox Sang 2007 0.75
142 [Multiple myeloma with high tumoral mass. Treatment combining melphalan, cyclophosphamide, vincristine, CCNU and prednisone. 35 cases]. Presse Med 1983 0.75
143 [Alveolar soft part sarcoma: a case report]. J Radiol 2009 0.75
144 [Diagnosis with hair]. Ann Pathol 2000 0.75
145 Case 52-1982: legionnaires' disease complicating hairy-cell leukemia. N Engl J Med 1983 0.75
146 [Cataract after bone marrow grafts]. Bull Soc Ophtalmol Fr 1987 0.75
147 Lymphadenopathy-associated virus/human T-lymphotropic virus type III in allogeneic bone marrow transplantation. Ann Intern Med 1986 0.75
148 [Diagnostic value of fiberoptic bronchoscopy in pneumopathies in immunodeficient adults: a report on 59 examinations (author's transl)]. Ann Med Interne (Paris) 1981 0.75
149 [Prospective monocentric evaluation of bladder tumor targeting by Hexvix® fluorescence: preliminary results]. Prog Urol 2010 0.75
150 Oxalate crystals in sputum of patients with aspergilloma. Am Rev Respir Dis 1986 0.75
151 [Answer to March e-quid. Pulmonary langerhans cell histiocytosis]. J Radiol 2010 0.75
152 [Nosocomial infections in neutropenic patients]. Rev Prat 1989 0.75
153 How many plasma exchanges to cure thrombotic thrombocytopenic purpura? Scand J Haematol 1985 0.75
154 Clonal T-cell colony formation in agar culture: an attractive assay to test the T-cell depletion from bone marrow. Exp Hematol 1986 0.75
155 Granulocyte-macrophage colony-stimulating factor in association to timed-sequential chemotherapy with mitoxantrone, etoposide, and cytarabine for refractory acute myelogenous leukemia. Leukemia 1993 0.75
156 [ABO incompatibility and non myeloablative allogeneic stem cell transplantation]. Transfus Clin Biol 2007 0.75
157 Successful engraftment after autologous transplantation of 10-day cultured bone marrow activated by interleukin 2 in patients with acute lymphoblastic leukemia. Bone Marrow Transplant 1995 0.75
158 Hepatic nodules as single organ involvement in an adult with Langerhans cell granulomatosis. A case report. J Clin Gastroenterol 1998 0.75
159 Sjögren syndrome: an unexpected disease occurring fourteen years after oligoarticular onset juvenile idiopathic arthritis. Rheumatology (Oxford) 2002 0.75
160 [Utilization of transfusions in the hematology clinic. Recommendations of the Evaluation Commission of the French College of Hematologists for transfusion support in the treatment of acute leukemia in therapeutic aplasia]. Nouv Rev Fr Hematol 1994 0.75
161 The topography of cortical microbleeds in frontotemporal lobar degeneration: a post-mortem 7.0-tesla magnetic resonance study. Folia Neuropathol 2016 0.75
162 Both human subcutaneous dirofilariasis cases previously diagnosed in Amiens (France) are probably not autochthonous. Parassitologia 1998 0.75
163 IgG subclass deficiency in acute myeloid leukemia. Nouv Rev Fr Hematol 1989 0.75
164 [Bacterial septicemia in neutropenia patients]. Ann Med Interne (Paris) 1983 0.75
165 Acral erythema and systemic toxicity related to CHA induction therapy in acute myeloid leukemia. Eur J Cancer Clin Oncol 1989 0.75
166 High dose intravenous gammaglobulin and platelet transfusions in leukaemic HLA-immunized patients. Scand J Haematol 1984 0.75
167 [Pancytopenia in acute brucellosis]. Rev Med Interne 1997 0.75
168 [Interstitial nephropathy with intracellular pigment deposits and chronic bisacodyl abuse]. Therapie 2001 0.75
169 [Calculation of direct standard costs in the evaluation of new technologies: application to the treatment of acute myeloblastic leukemias]. Rev Epidemiol Sante Publique 1986 0.75
170 [Cellular neurothekeoma, a rare cutaneous tumor. Anatomo-clinical and immunohistochemical study of 2 cases]. Ann Pathol 2000 0.75
171 [Splenic angiosarcoma: a case report with synchronous hepatic metastases]. Chirurgie 1999 0.75
172 [Thrombocytopenic thrombotic purpura in adults. 10 cases (author's transl)]. Nouv Presse Med 1980 0.75
173 HLA-DR restriction in suppression of hematopoiesis by T cells from allogeneic bone marrow transplants. J Immunol 1986 0.75
174 Direct vascular actions of methyclothiazide in remodeled mesenteric arteries from hypertensive patients. Am J Hypertens 2001 0.75
175 [Reduction of the post-transfusion hepatitis C risk in patients undergoing bone marrow allograft]. Rev Fr Transfus Hemobiol 1993 0.75
176 [Muscular haematoma in Henoch-Schönlein purpura]. Rev Med Interne 2004 0.75
177 [A cutaneous neck flow]. Ann Pathol 2000 0.75
178 Lacrymal gland enlargement as a presenting feature of Wegener's granulomatosis. Eur J Med 1993 0.75
179 [Evaluation of computer tomography in the diagnosis of postoperative intraperitoneal septic foci]. Agressologie 1980 0.75
180 Bacterial translocation, intestinal morphology, and enzyme activities after ileal ischemia in newborn piglets. Pediatr Surg Int 1996 0.75
181 Lack of evidence of heterozygosity for cystic fibrosis as a risk factor for invasive aspergillosis in haematological patients. Eur J Clin Microbiol Infect Dis 1999 0.75
182 [Papillary fibroelastoma. Report of 3 cases]. Arch Mal Coeur Vaiss 1999 0.75
183 Allogeneic bone marrow transplantation in adults with Burkitt's lymphoma or acute lymphoblastic leukemia in first complete remission. J Clin Oncol 1990 0.75
184 [Metastatic lesions of soft tissue of the fingers. Apropos of a case treated by excision and immediate reconstruction]. Rev Chir Orthop Reparatrice Appar Mot 1993 0.75
185 [Inflammatory pseudotumors of the liver. Apropos of a pediatric case with radiological and ultrasonographic features and anatomopathological correlations]. J Radiol 1998 0.75
186 Cost of allogeneic bone marrow transplantation in four diseases. Health Policy 1989 0.75
187 [Tenography in tenosynoviopathies of the posterior tibial tendon]. Rev Chir Orthop Reparatrice Appar Mot 1996 0.75
188 Localized meningeal blast crisis revealing chronic myeloid leukaemia. Br J Haematol 1984 0.75
189 Reconstitution of cytotoxic T lymphocyte activity following allogeneic bone marrow transplantation in man. Transplantation 1987 0.75
190 Radiation-induced bone sarcoma following total body irradiation: role of additional radiation on localized areas. Bone Marrow Transplant 2000 0.75
191 [Acute mast cell leukemia disclosed by vasomotor flushing]. Ann Dermatol Venereol 1997 0.75
192 Clofarabine as a potential stimulant of alloreactivity. Bone Marrow Transplant 2010 0.75
193 Serum IgG subclasses in secondary immunodeficiencies. Monogr Allergy 1988 0.75
194 Enhancement of alloimmunization: a potential hazard of GM-CSF treatment in patients with severe aplastic anemia? Transfusion 1989 0.75
195 [Renal transitional carcinoma and caval tumor thrombus]. Prog Urol 2001 0.75
196 [Mixed lympho-epidermal cell cultures: value in bone marrow grafts]. Presse Med 1989 0.75
197 [Sequential chemotherapy with or without GM-CSF in acute myeloid leukemia (AML) in the advanced phase: current status of protocols EMA 86 and EMA 91]. Nouv Rev Fr Hematol 1994 0.75
198 Outcome after allogeneic transplantation for adult acute myeloid leukemia patients exhibiting isolated or associated trisomy 8 chromosomal abnormality: a survey on behalf of the ALWP of the EBMT. Bone Marrow Transplant 2009 0.75
199 [Hypoxemic acute diffuse pneumopathy in therapeutic aplasia for acute myeloid leukemia]. Rev Pneumol Clin 1998 0.75
200 [Lung complications of hematopoietic stem cell transplantation]. Rev Mal Respir 1996 0.75
201 Aβ1-40 and Aβ1-42 plasmatic levels in stroke: influence of pre-existing cognitive status and stroke characteristics. Curr Alzheimer Res 2015 0.75
202 Mixed epidermal cell-lymphocyte reaction in prediction of acute graft-versus-host disease in bone marrow recipients. J Natl Cancer Inst 1986 0.75
203 [Haemophilus influenzae infections after bone marrow grafting: from observation to prevention]. Rev Pneumol Clin 1995 0.75
204 Additional total-lymphoid irradiation in preventing graft failure of T-cell-depleted bone marrow transplantation from HLA-identical siblings. Results of a prospective randomized study. Transplantation 1988 0.75
205 Rate of intravenous thrombolysis for acute ischaemic stroke in the North-of-France region and evolution over time. J Neurol 2014 0.75
206 [Evaluation of the quality drug prescription for patients to be discharged from a university teaching hospital: statutory aspects]. Ann Pharm Fr 2001 0.75
207 [Bacterial resistance and management of nosocomial infections: relations to hematology]. Pathol Biol (Paris) 1996 0.75
208 [Apropos of the case reported by M. Leporrier et al., on mixed nodular lymphoma associated with a deficiency of C1-esterase inhibitor]. Nouv Rev Fr Hematol 1981 0.75
209 [Value of a fraction of low molecular weight heparin, enoxaparine, in patients at high risk of hemorrhage and thrombosis]. Ann Med Interne (Paris) 1988 0.75
210 [Plurifocal testicular hamartomas and testicular feminization syndrome]. Ann Pathol 2000 0.75
211 Chimerism analysis by lineage-specific fluorescent polymerase chain reaction in secondary graft failure after allogeneic stem cell transplantation. Transplantation 2001 0.75
212 [An uncommon lesion of the prostatic urethra. Report of two cases]. Ann Pathol 2001 0.75
213 [Parsonage-Turner syndrome disclosing HIV seropositivity]. Ann Med Interne (Paris) 1993 0.75
214 [Congenital mesoblastic nephroma: diagnosis and treatment of one case]. Prog Urol 2011 0.75
215 [Mortal acute aspergillosis bronchitis]. Nouv Presse Med 1978 0.75
216 [Disseminated aspergillosis in acute leukemia probably chemically-induced]. Nouv Rev Fr Hematol 1986 0.75
217 Use of the calcium agonist BAY K 8644 for in vitro diagnosis of susceptibility to malignant hyperthermia. Br J Anaesth 1990 0.75
218 Intracerebral haemorrhage and cognitive decline. Rev Neurol (Paris) 2013 0.75
219 [Influence of clinical status on the efficacy of stored platelet transfusion]. Rev Fr Transfus Hemobiol 1993 0.75
220 Human herpesvirus 6 infection in patients with exanthema after allogeneic bone marrow transplantation. Arch Dermatol 1998 0.75
221 [Transfusion strategy for patients in therapeutic aplasia. Experience of the Henri Mondor Hospital apropos of 2 successive protocols]. Rev Fr Transfus Immunohematol 1987 0.75
222 The mixed epidermal cell lymphocyte-reaction is the most predictive factor of acute graft-versus-host disease in bone marrow graft recipients. Br J Haematol 1988 0.75
223 Legionnaires' disease and hairy-cell leukemia. An unfortuitous association? Arch Intern Med 1984 0.75
224 Hematopoietic growth factors in treatment of necrotizing cellulitis patients with drug-induced neutropenia. Dermatology 1993 0.75